250 Participants Needed

Personalized Indoor Air Quality Reports for Improving Indoor Air Quality

Recruiting at 1 trial location
EC
HC
Overseen ByHope Cruse
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Colorado State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial does not specify whether you need to stop taking your current medications. It focuses on improving indoor air quality and does not mention any medication requirements.

What data supports the effectiveness of the treatment Home Health Report for improving indoor air quality?

Research shows that using in-home air quality sensors and air cleaners can help reduce indoor pollutants like NO2 and improve respiratory health, as seen in studies with asthma and COPD patients. Personalized air quality monitoring has been effective in managing asthma by identifying pollution sources and exposure levels.12345

Is it safe to use personalized indoor air quality reports for improving indoor air quality?

The studies reviewed focus on monitoring indoor air quality to manage asthma, using sensors to track pollutants like particulate matter and gases such as NO2 and ozone. These systems have been successfully deployed in homes without reported safety issues, suggesting they are generally safe for use in monitoring air quality.26789

How does the treatment of personalized indoor air quality reports differ from other treatments for improving indoor air quality?

This treatment is unique because it provides personalized indoor air quality reports using real-time data from cloud-connected sensors, allowing individuals to understand and manage their specific exposure to pollutants like NO2 and ozone, which is not typically addressed by standard air quality treatments.26101112

What is the purpose of this trial?

The goal of this clinical trial is to learn about whether indoor air quality will improve over time in homes where occupants receive personalized information about levels of health-relevant air pollutants that includes practical, budget-friendly, and culturally relevant recommendations on actions they can take to improve their home's air quality. The rationale for the investigators' approach is that a rigorous intervention study design will generate robust evidence on the value of the in-home environmental data. Participating homes in both the intervention and control groups will receive three, one-week Home Health Box deployments spaced six weeks apart. After each of the first two deployments, homes in the intervention group will receive a Home Health Report with personalized information about in-home levels of health-relevant air pollutants and cost-sensitive recommendations on actions occupants can take to improve their home's air quality. The investigators will (a) investigate whether and how air quality changes over time in control and intervention homes and (b) survey intervention households on the utility of the Home Health Reports.

Research Team

EC

Ellison Carter, PhD

Principal Investigator

Colorado State University

Eligibility Criteria

This trial is for individuals who will be living in their current home for at least the next six months. It's not suitable for those planning to move within six months of starting the study.

Inclusion Criteria

You are residing in a dwelling for the next six months.

Exclusion Criteria

Participants will not be living in the same household within six months of enrollment

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive personalized Home Health Reports and Home Health Box deployments to monitor and improve indoor air quality

4-6 months
3 in-home visits for air quality monitoring

Follow-up

Participants are surveyed on the utility of the Home Health Reports and receive a comprehensive report at the end of the study

4 weeks

Treatment Details

Interventions

  • Home Health Report
Trial Overview The study tests if indoor air quality improves when occupants get a Home Health Report with data on air pollutants and tips to enhance air quality. Homes are monitored over time, comparing those receiving reports with control homes that do not.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The Home Health Report will provide quantitative information about health-relevant pollutants (fine particulate matter, carbon dioxide, nitrogen dioxide, and volatile organic compounds), their levels compared to health-based guidelines, their potential sources, as well as no- and low-cost actions occupants could take to improve indoor air quality. The Home Health Report will be designed to maximize utility to residents. Each Home Health Report will be provided after the corresponding Home Health Box deployment. The second Home Health Box deployment will occur after the household receiving their first Home Health Report. The third and final Home Health Box deployment will occur within one month of the household receiving their second Home Health Report.
Group II: ControlActive Control1 Intervention
Households in the control group will also receive three Home Health deployments spaced over several months, but will not receive Home Health Reports after the first and second deployments. At the close of their participation in the study, households in the control group will receive a comprehensive Home Health Report, including results from all three Home Health Box deployments and recommended actions occupants could take to improve their home air quality.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Colorado State University

Lead Sponsor

Trials
138
Recruited
38,200+

University of Colorado, Denver

Collaborator

Trials
1,842
Recruited
3,028,000+

Access Sensor Technologies, LLC

Collaborator

Trials
1
Recruited
250+

Findings from Research

In a 6-month study involving 116 former smokers with COPD, 76.1% of participants adhered to using portable air cleaners at least 80% of the time, which could potentially improve their respiratory health by reducing indoor pollutants.
Factors such as higher household income and using electric heating were linked to better adherence, while lower quality of life and recent exacerbations were associated with lower adherence, indicating that socioeconomic and health status play crucial roles in the effectiveness of air cleaner interventions.
Patterns and Predictors of Air Cleaner Adherence Among Adults with COPD.Lorizio, W., Woo, H., McCormack, MC., et al.[2022]
A cloud-connected indoor air quality sensor system was developed to monitor pollutants like NO2 and ozone in real-time, providing valuable data for asthma research and management in patients' homes.
In a pilot study with pediatric asthma patients, some families experienced NO2 levels exceeding the EPA's safe exposure limit, highlighting the potential health risks associated with indoor air pollution from natural gas appliances.
A Cloud-connected NO2 and Ozone Sensor System for Personalized Pediatric Asthma Research and Management.Dong, Q., Li, B., Downen, RS., et al.[2021]
In a study of 60 children with cystic fibrosis, those using electronic home spirometry showed a significant improvement in lung function, with a 5% increase in FEV1 for adherent users compared to a 2.5% decrease in the usual care group.
The use of home spirometry also led to a notable improvement in the social quality of life domain for patients, indicating that electronic monitoring can enhance both health outcomes and overall well-being.
Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV1.Yanaz, M., Yilmaz Yegit, C., Gulieva, A., et al.[2023]

References

Patterns and Predictors of Air Cleaner Adherence Among Adults with COPD. [2022]
A Cloud-connected NO2 and Ozone Sensor System for Personalized Pediatric Asthma Research and Management. [2021]
Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV1. [2023]
Toward an asthma patient-reported outcome measure for use in digital remote monitoring. [2022]
Modeling residential indoor concentrations of PM2.5 , NO2 , NOx , and secondhand smoke in the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) Air study. [2022]
Investigation of an Indoor Air Quality Sensor for Asthma Management in Children. [2020]
Feasibility and acceptability of monitoring personal air pollution exposure with sensors for asthma self-management. [2022]
One-year dataset of hourly air quality parameters from 100 air purifiers used in China residential buildings. [2023]
Reporting Results of a Community-Based In-Home Exposure Monitoring Study: Developing Methods and Materials. [2021]
One Year Evaluation of Three Low-Cost PM2.5 Monitors. [2021]
Using low-cost sensors to assess real-time comfort and air quality patterns in indoor households. [2023]
Developing a smartphone software package for predicting atmospheric pollutant concentrations at mobile locations. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security